NLRP3 and cryopyrin-associated periodic syndrome: Studies proved that inhibition of BTK ameliorated NLRP3 activation and improved ischemic brain injury in peripheral blood mononuclear cells (PBMCs) of patients with CAPS (Ito et al. 2015; Mangan et al. 2018).